Skip to main content

Peer Review reports

From: Tivozanib in renal cell carcinoma: a systematic review of the evidence and its dissemination in the scientific literature

Original Submission
9 Mar 2021 Submitted Original manuscript
16 Aug 2021 Reviewed Reviewer Report
12 Jan 2022 Reviewed Reviewer Report - Roger A'Hern
4 Feb 2022 Author responded Author comments - Laura Caquelin
Resubmission - Version 2
4 Feb 2022 Submitted Manuscript version 2
16 Feb 2022 Author responded Author comments - Laura Caquelin
Resubmission - Version 3
16 Feb 2022 Submitted Manuscript version 3
29 Mar 2022 Author responded Author comments - Laura Caquelin
Resubmission - Version 4
29 Mar 2022 Submitted Manuscript version 4
Publishing
31 Mar 2022 Editorially accepted
9 Apr 2022 Article published 10.1186/s12885-022-09475-7

You can find further information about peer review here.

Back to article page